fusidic acid has been researched along with virginiamycin in 10 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (virginiamycin) | Trials (virginiamycin) | Recent Studies (post-2010) (virginiamycin) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 1,247 | 59 | 101 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
Derambure, S; Deroubaix, P; Hogedez, G; Lelong, M; Polaert, J; Sorez, JP; Thelliez, P; Vanlaeys, R | 1 |
Roser, H | 1 |
Legler, F | 1 |
Knoll, KH | 1 |
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
Autret-Leca, E; Barruet, R; Jehl, F; Le Guellec, C; Lorette, G; Roiron, R; Sorensen, H; Vaillant, L | 1 |
Claudy, A | 1 |
Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
1 trial(s) available for fusidic acid and virginiamycin
Article | Year |
---|---|
[Superficial pyoderma requiring oral antibiotic therapy: fusidic acid versus pristinamycin]].
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Costs and Cost Analysis; Data Interpretation, Statistical; Double-Blind Method; Female; Fusidic Acid; Humans; Male; Middle Aged; Placebos; Pyoderma; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections; Time Factors; Virginiamycin | 2001 |
9 other study(ies) available for fusidic acid and virginiamycin
Article | Year |
---|---|
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
[Antibiotic resistance of Staphylococcus aureus isolated rom children. Comparative evolution between 1967 and 1972].
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Fusidic Acid; Gastroenteritis; Gentamicins; Humans; Infant; Otitis; Respiratory Tract Infections; Skin Diseases; Staphylococcal Food Poisoning; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Virginiamycin | 1973 |
[Determination of resistance to the antibiotic staphylomycin].
Topics: Anti-Bacterial Agents; Chloramphenicol; Cloxacillin; Erythromycin; Fusidic Acid; Methicillin; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcus; Streptomycin; Tetracycline; Virginiamycin | 1966 |
[Present resistance status of Staphylococcus aureus under specific consideration of the antibiotics virgimycia, cephalothin and fusidic acid].
Topics: Adult; Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalothin; Child; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Neomycin; Nitrofurantoin; Oleandomycin; Penicillin G; Penicillin Resistance; Penicillin V; Staphylococcus; Streptomycin; Sulfonamides; Tetracycline; Virginiamycin | 1967 |
[Sensitivity of Staphylococci and enterococci to staphylomycin with special consideration of urine-bacteria].
Topics: Anti-Bacterial Agents; Bacteriuria; Bile; Chloramphenicol; Enterococcus faecalis; Erythromycin; Fusidic Acid; Humans; Immunodiffusion; Kanamycin; Oxacillin; Penicillin G; Penicillin Resistance; Sputum; Staphylococcus; Suppuration; Tetracycline; Virginiamycin | 1969 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
[Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Diffusion; Extracellular Space; Fusidic Acid; Humans; Male; Oxacillin; Penicillins; Skin; Time Factors; Virginiamycin | 2000 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |